The COVID Project
The record
- Jurisdiction
- United States (federal); Drug Enforcement Administration, Diversion Control Division
- Level
- Federal
- Authority
- 21 C.F.R. 1307.03; exception to 21 C.F.R. 1301.74(e) (signature on delivery of narcotics to NTPs)
- Issued
- 2020-04-10 Apr. 10, 2020
- Effective
- 2020-04-10 (digitally signed Apr. 11, 2020) (read as 2020-04-10)
- End
- For the duration of the public health emergency (read as 2021-09-30)
- In force
- Apr. 10, 2020 to Sept. 30, 2021
- Quarters
- 2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3
- Limitation types
- Supply chainOther
- Addressees
- DEA-registered distributors
- DEA-registered manufacturers
- Functions reached
- SC supply chain
- WH shipping and receiving
- DR drivers (contactless delivery)
- Collection
- Other federal health agencies AGY-FED-HEALTH-OTHER
Operative words
In order to allow NTP personnel the ability to comply with recommended basic protective measures and social distancing guidelines for the duration of this public health emergency, DEA is granting an exception to the provision of 21 CFR 1301.74(e) that requires a signature on delivery.
Enforcement
Registrant security requirements under 21 U.S.C. 823 and 842
Notes
Pharmaceutical distributors changed delivery protocols nationwide.